SCHEMBL9917628

SCHEMBL9917628

O=C(C[C@H]1NC(=O)OC1=O)OCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.55
ALDH1A1 P00352 3/20 0.47
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CDC25B P30305 1/20 0.41
USP2 O75604 1/20 0.41
KMT2A Q03164 2/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A3 Q01959 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
MMP12 P39900 1/20 0.40
CYP1A2 P05177 1/20 0.39
P2RX1 P51575 1/20 0.39
P2RX3 P56373 1/20 0.39
P2RX4 Q99571 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4413019 1.00 GLA (0.55) GLAALDH1A1MAPK1L3MBTL1CDC25B
SCHEMBL9886347 1.00 GLA (0.55) GLAALDH1A1MAPK1L3MBTL1CDC25B
SCHEMBL7013306 0.86 ALDH1A1 (0.45) GLAALDH1A1MAPK1L3MBTL1CDC25B
SCHEMBL12086008 0.86 ALDH1A1 (0.45) GLAALDH1A1MAPK1L3MBTL1CDC25B
SCHEMBL11957431 0.86 GLA (0.53) GLAALDH1A1MAPK1L3MBTL1CDC25B
SCHEMBL4415882 0.86 ALDH1A1 (0.45) GLAALDH1A1MAPK1L3MBTL1CDC25B
SCHEMBL22817371 0.84 ALDH1A1 (0.43) GLAALDH1A1MAPK1L3MBTL1CDC25B
SCHEMBL9191194 0.80 LMNA (0.48) ALDH1A1
SCHEMBL7324582 0.80 LMNA (0.48) ALDH1A1
SCHEMBL7323991 0.80 LMNA (0.48) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022136366-A1 NOVEL METHOD FOR SYNTHESIZING NCA COMPOUNDS ECOLE NATIONALE SUPERIEURE DE CHIMIE DE MONTPELLIER (ENSCM) (FR) 2022-06-30 WO disclosed
US-8747904-B2 Polymeric micelles for polynucleotide encapsulation INTEZYNE TECHNOLOGIES, INC. (US) 2014-06-10 US disclosed
US-8287910-B2 Polymeric micelles for polynucleotide encapsulation INTEZYNE TECHNOLOGIES, INC. (US) 2012-10-16 US disclosed
US-8287910-B2 Polymeric micelles for polynucleotide encapsulation INTEZYNE TECHNOLOGIES, INC. (US) 2012-10-16 US disclosed
US-20120148631-A1 PEGYLATED POLYPLEXES FOR POLYNUCLEOTIDE DELIVERY INTEZYNE TECHNOLOGIES, INCORPORATED (US) 2012-06-14 US disclosed
US-20120148631-A1 PEGYLATED POLYPLEXES FOR POLYNUCLEOTIDE DELIVERY INTEZYNE TECHNOLOGIES, INCORPORATED (US) 2012-06-14 US disclosed
WO-2011130577-A1 CONTROLLED POLYPLEX ASSEMBLY INTEZYNE TECHNOLOGIES, INCORPORATED (US) 2011-10-20 WO disclosed
US-20110256227-A1 CONTROLLED POLYPLEX ASSEMBLY INTEZYNE TECHNOLOGIES, INC. (US) 2011-10-20 US disclosed
US-20110256227-A1 CONTROLLED POLYPLEX ASSEMBLY INTEZYNE TECHNOLOGIES, INC. (US) 2011-10-20 US disclosed
US-20110229528-A1 PEGYLATED POLYPLEXES FOR POLYNUCLEOTIDE DELIVERY INTEZYNE TECHNOLOGIES, INCORPORATED (US) 2011-09-22 US disclosed
US-20110142886-A1 PEGYLATED POLYPLEXES FOR POLYNUCLEOTIDE DELIVERY INTEZYNE TECHNOLOGIES, INCORPORATED (US) 2011-06-16 US disclosed
US-20110142886-A1 PEGYLATED POLYPLEXES FOR POLYNUCLEOTIDE DELIVERY INTEZYNE TECHNOLOGIES, INCORPORATED (US) 2011-06-16 US disclosed
WO-2011068916-A1 PEGYLATED POLYPLEXES FOR POLYNUCLEOTIDE DELIVERY INTEZYNE TECHNOLOGIES, INCORPORATED (US) 2011-06-09 WO disclosed
US-20100292432-A1 POLYMERS FOR POLYNUCLEOTIDE ENCAPSULATION INTEZYNE TECHNOLOGIES, INCORPORATED (US) 2010-11-18 US disclosed
US-20100278927-A1 POLYMERIC MICELLES FOR POLYNUCLEOTIDE ENCAPSULATION INTEZYNE TECHNOLOGIES, INCORPORATED (US) 2010-11-04 US disclosed
US-20100278927-A1 POLYMERIC MICELLES FOR POLYNUCLEOTIDE ENCAPSULATION INTEZYNE TECHNOLOGIES, INCORPORATED (US) 2010-11-04 US disclosed
US-20090286938-A1 SYNTHESIS OF HYBRID BLOCK COPOLYMERS FROM DIFLUOROACETATE AMMONIUM SALTS INTEZYNE TECHNOLOGIES, INC. (US) 2009-11-19 US disclosed
US-20090286938-A1 SYNTHESIS OF HYBRID BLOCK COPOLYMERS FROM DIFLUOROACETATE AMMONIUM SALTS INTEZYNE TECHNOLOGIES, INC. (US) 2009-11-19 US disclosed
WO-2009134984-A1 SYNTHESIS OF HYBRID BLOCK COPOLYMERS FROM DIFLUOROACETATE AMMONIUM SALTS INTEZYNE TECHNOLGIES INC. (US) 2009-11-05 WO disclosed
WO-2008134734-A2 ENCAPSULATED CONTRAST AGENTS INTEZYNE TECHNOLOGIES, INC. (US) 2008-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110142886-A1 PEGYLATED POLYPLEXES FOR POLYNUCLEOTIDE DELIVERY PARN, PUF60, PARG GLA 2787/4885ALDH1A1 4268/4885MAPK1 4294/4885
US-20120148631-A1 PEGYLATED POLYPLEXES FOR POLYNUCLEOTIDE DELIVERY PARN, PUF60, PARG GLA 2787/4885ALDH1A1 4268/4885MAPK1 4294/4885
US-20090286938-A1 SYNTHESIS OF HYBRID BLOCK COPOLYMERS FROM DIFLUOROACETATE AMMONIUM SALTS PFAS, GFPT1, PFKFB4 GLA 2727/4885ALDH1A1 3301/4885MAPK1 4126/4885
US-20100278927-A1 POLYMERIC MICELLES FOR POLYNUCLEOTIDE ENCAPSULATION NCL, POLN, CHMP4B GLA 4652/4885ALDH1A1 4847/4885MAPK1 4622/4885
US-20110229528-A1 PEGYLATED POLYPLEXES FOR POLYNUCLEOTIDE DELIVERY PARN, PUF60, PARG GLA 2787/4885ALDH1A1 4268/4885MAPK1 4294/4885
US-20110256227-A1 CONTROLLED POLYPLEX ASSEMBLY PARG, PARN, PUF60 GLA 4605/4885ALDH1A1 4749/4885MAPK1 4669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.